Comprehensive clinical review highlights AUA/SUFU guidelines for neurogenic bladder management in women, indicating implications for OB/GYNs.
This article reviews the latest American Urological Association (AUA)/Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) guidelines on neurogenic lower urinary tract dysfunction (NLUTD), with a specific focus on implications for obstetricians and gynecologists. It aims to provide a clinically relevant synthesis for OB/GYNs managing women with neurogenic bladder conditions. Recent evidence emphasizes stratified risk assessment, clean intermittent catheterization (CIC) as a protective standard, and early identification of high-risk features such as poor bladder compliance and detrusor-sphincter dyssynergia. New insights also highlight obstetric complications, autonomic dysreflexia, and the utility of neuromodulation and botulinum toxin in selected patients. Effective multidisciplinary care for women with NLUTD requires familiarity with current guidelines. OB/GYNs play a vital role in pregnancy counseling, perioperative care, and bladder health maintenance. Integration of urologic principles into gynecologic practice can improve patient outcomes, reduce complications, and support reproductive goals in this population.
No takes yet. Share an insight, caveat, or question.
Molina et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: